JSI Endorses Two-Drug Initiative To Prevent Maternal, Infant Mortality

Huffington Post: Simple Solutions to Global Problems: How Two Medicines Promise Life for Mothers and Infants in Nigeria
Joel Lamstein, president of JSI and World Education

“…[W]ith support from donors such as USAID, JSI is pioneering a two-drug initiative that uses low-tech and high-impact methods to protect both mother and newborn during and after birth. The first drug, misoprostol, is for the mother to take immediately after delivery. Just three orally ingested pills prevent postpartum hemorrhage, a leading cause of maternal mortality around the world. A second medicine, chlorhexidine, is an easy-to-use antiseptic to replace traditional umbilical cord care. … By ensuring that more newborns live and fewer mothers die, chlorhexidine and misoprostol promise families better futures…” (6/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.